BDPT · Bioadaptives, Inc.
$0.00
+0.00 (+0.00%)
At close · Aug 28
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.”View the 10-Q filed Aug 19, 2026
Market Cap
$275,695
Shares
196.93M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Reed Harris | Advisory Board | Appointed | 2025-02-07 |
| Mark Frissora | Board of Directors | Appointed | 2025-02-07 |
| James Keener | CEO | Appointed | 2024-05-22 |
| Robert Ellis | President | Resigned | 2024-05-22 |
| Edward Jacobs | CEO | Resigned | 2024-05-22 |
| James Keener | Chairman of the Board | Appointed | 2024-05-22 |
| Robert Ellis | Board Member | Resigned | 2024-05-22 |
| Edward Jacobs | Chairman of the Board | Resigned | 2024-05-22 |
| Yaguang Liu | Board of Directors | Appointed | 2023-04-06 |
| Ronald Lambrecht | Chief Financial Officer | Appointed | 2021-06-11 |
| Robert W. Ellis | director | Appointed | 2021-06-11 |
| Charles Townsend | director | Appointed | 2021-06-11 |
| Charles Townsend | Chief Operating Officer | Appointed | 2021-06-11 |
| Ronald Lambrecht | CHIEF FINANCIAL OFFICER and SECRETARY/TREASURER | Appointed | 2021-06-11 |
| Charles Townsend | director | Appointed | 2021-06-11 |
| Robert Ellis | director | Appointed | 2021-06-11 |
| Charles Townsend | Chief Operating Officer | Appointed | 2021-06-11 |
Key facts
CIK
1575142